Clinical trial
The Impact of Tosylate Remimazolam on Oxygenation and Postoperative Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy
NCT07086911 is registered in ClinicalTrials.gov with Jinqiao Qian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Tosylate Remimazolam on Oxygenation and Postoperative Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy
- Lead sponsor
- Jinqiao Qian
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- August 31, 2025
- Completion date
- December 31, 2026
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oxygenation, postoperative cognitive dysfunction, remimazolam besylate, thoracoscopic lobectomy